SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Annette E. Hay, Ralph M. Meyer, Balancing Risks and Benefits of Therapy for Patients with Favorable-Risk Limited-Stage Hodgkin Lymphoma, Hematology/Oncology Clinics of North America, 2014, 28, 1, 49

    CrossRef

  2. 2
    G. Rauch, J. Beyersmann, Planning and evaluating clinical trials with composite time-to-first-event endpoints in a competing risk framework, Statistics in Medicine, 2013, 32, 21